Form 4 Filing for Aquestive Therapeutics, Inc.

This filing reports a transaction by Sherry Korczynski, Chief Commercial Officer of Aquestive Therapeutics, Inc. On June 8, 2026, 2,714 shares of Common Stock were withheld by the Issuer to satisfy tax obligations related to the vesting of Restricted Stock Units (RSUs). The transaction code is "F" and the disposition code is "D". Following this transaction, Ms. Korczynski holds 238,403 shares. The filing also includes a Power of Attorney document authorizing Thomas A. Zalewski and others to execute and file necessary SEC forms on behalf of the reporting person.